55KRC: UC launches new stroke study
January 31, 2022
55KRC's Simply Medicine program highlighted the University of Cincinnati's Dr. Joseph Broderick and the FASTEST stroke clinical trial.
January 31, 2022
55KRC's Simply Medicine program highlighted the University of Cincinnati's Dr. Joseph Broderick and the FASTEST stroke clinical trial.
September 11, 2024
The University of Cincinnati's Joseph Broderick was featured in an MSN article highlighting the FASTEST trial testing a drug to treat stroke due to intracerebral hemorrhage, when blood vessels in the brain rupture and cause bleeding in the brain.
July 12, 2024
The University of Cincinnati's Pooja Khatri commented to TCT MD on the RAISE trial that found drug reteplase may be a safe and effective option to treat acute ischemic stroke.
November 8, 2022
The University of Cincinnati's Stacie Demel, DO, PhD, joined the Simply Medicine podcast to discuss TNK, a new treatment for acute ischemic stroke now available to patients across Greater Cincinnati.
November 3, 2022
The University of Cincinnati's Rhonna Shatz was featured in a U.S. News and World Report article on signs that a patient with dementia may need a higher level of care.
May 18, 2022
The University of Cincinnati's Eva Mistry and Pooja Khatri were recent guests on local news programs to discuss National Stroke Awareness Month.
July 25, 2022
The University of Cincinnati's Hyacinth I. Hyacinth was a guest on 55KRC's Simply Medicine program to discuss his research into sickle cell disease, stroke and cognitive impairment.
August 11, 2022
The University of Cincinnati's Joseph Broderick, MD, provided comments in a TCTMD article reviewing the results of a recent study that found administering the drug tirofiban before endovascular thrombectomy does not improve functional outcomes in patients.
September 28, 2022
The University of Cincinnati's Alberto Espay, MD, was featured in an NBC News article reporting on results from a phase three Alzheimer's drug trial.
December 8, 2023
The University of Cincinnati's Pooja Khatri and Eva Mistry spoke with Local 12 about the SISTER trial that will test a new drug to treat patients with strokes who are not eligible to receive traditional treatments due to timing factors or risk of complications.